Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1Recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Dermatologic 2

Conditions

Melanoma 783Carcinoma, Non-Small-Cell Lung 170Skin Neoplasms 154Neoplasms 106Neoplasm Metastasis 100Colorectal Neoplasms 97Carcinoma, Renal Cell 95Uveal Melanoma 92Breast Neoplasms 88Squamous Cell Carcinoma of Head and Neck 85Carcinoma, Basal Cell 83Lung Neoplasms 81Ovarian Neoplasms 79Sarcoma 67Lymphoma, T-Cell, Cutaneous 66Carcinoma, Merkel Cell 66Stomach Neoplasms 58Pancreatic Neoplasms 58Head and Neck Neoplasms 55Carcinoma, Hepatocellular 53Uterine Cervical Neoplasms 52Urinary Bladder Neoplasms 50Esophageal Neoplasms 44Prostatic Neoplasms 43Triple Negative Breast Neoplasms 42Endometrial Neoplasms 41Carcinoma, Squamous Cell 39Brain Neoplasms 39Carcinoma, Transitional Cell 37Lymphoma 35

Interventions

Physical Examination 1Nerve Block 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Skin Cancer Face × Dermatologic × 1 year × Clear all
NCT07222241 2026-05-29

Comparing Numbing Techniques in Mohs Micrographic Surgery

Abramson Cancer Center at Penn Medicine

Phase NA Recruiting
150 enrolled
Dermatologic

Skin Cancer Face

NCT03382704 2026-01-16

Vellus Hair Loss as a Marker for Peri-ocular Malignancy

NHS Lothian

Withdrawn
Dermatologic

Skin Cancer Face

Data powered by HemOnc (CC BY 4.0) Colophon âš¡